Anavex Life Sciences Corp (AVXL)

[sokol]

Yes, and during that 5 year period, Anavex may be able to develop an improved version AVXL 2-73 that they and their partner could switch the market to upon expiration of the 5-year exclusivity. For example, if AVXL 2-73 may be combined with another chemical entity that will be more effective than 2-73 alone, it may be that his combination is patentable.